|
Optimized UHPLC–Derivatization Method for Low-Level Nitrite Detection in Pharmaceutical Excipients-Pub
|
|
0
|
55
|
March 23, 2026
|
|
Impact of post approval quantitative changes in excipient composition on nitrosamine formation: De-risking strategy-Pub
|
|
0
|
44
|
March 23, 2026
|
|
MEGLUMINE (Methylglucamine)
|
|
28
|
3576
|
March 16, 2026
|
|
Nitrites/Nitrosamines: The impacts on analytics, but not only
|
|
0
|
167
|
February 17, 2026
|
|
Nitrosamine Impurities: The Analytical & Regulatory Roadmap (2024-2025)
|
|
0
|
374
|
January 20, 2026
|
|
Nitrosamine Impurities in Excipients
|
|
11
|
516
|
January 8, 2026
|
|
Nitrites in Excipients
|
|
7
|
475
|
November 28, 2025
|
|
IPEC Excipient new questionnaire, October 2025
|
|
2
|
245
|
October 23, 2025
|
|
Updated: IPEC Questionnaire for Excipient Nitrosamines Risk Evaluation
|
|
2
|
596
|
October 23, 2025
|
|
Nitrite testing in Excipients
|
|
2
|
537
|
August 17, 2025
|
|
Nitrosamines excipient EDTA
|
|
3
|
393
|
June 12, 2025
|
|
Interferencia de matriz para cuantificación de NDBA
|
|
0
|
87
|
May 5, 2025
|
|
Can Ionized Air in Pharma Pose a Risk of Nitrite Formation
|
|
4
|
428
|
March 10, 2025
|
|
Impact of Antioxidant Excipients on N-nitrosamine Formation and Bioequivalence in Metformin Formulations - Pub
|
|
3
|
758
|
February 11, 2025
|
|
Low nitrite excipients
|
|
11
|
3032
|
November 27, 2024
|
|
Nitrosamnes in PMs & Excipients Questions
|
|
5
|
1120
|
November 22, 2024
|
|
Managing Nitrite Impurities: A Supplier-Manufacturer Approach to Mitigate Nitrosamine Risk
|
|
2
|
703
|
October 18, 2024
|
|
Primeros pasos para evaluar nitrosaminas en medicamentos
|
|
5
|
285
|
September 23, 2024
|
|
Determining Low PPB Levels of Nitrite in Polymeric Excipients
|
|
0
|
284
|
September 10, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
22
|
1733
|
September 5, 2024
|
|
4-(nitroso(vinyl)amino)butanoic acid from Kollidon?
|
|
7
|
504
|
August 29, 2024
|
|
IPEC Webinar on the role of excipients in determine N-nitrosamine risks
|
|
3
|
498
|
July 24, 2024
|
|
Parts per billion of nitrite in microcrystalline cellulose -Pub
|
|
3
|
1174
|
July 3, 2024
|
|
Risk analysis of nitrosamine impurities in liquid products (essences and flavors)
|
|
3
|
769
|
June 28, 2024
|
|
Insights from the Lhasa Limited and IPEC Europe Nitrites collaborative meeting
|
|
1
|
554
|
June 16, 2024
|
|
Lactose, Nitrosamine Risk?
|
|
35
|
3604
|
April 6, 2022
|
|
Update: EFPIA workflows for Quality Risk management Jun 2024 v03
|
|
2
|
1288
|
June 4, 2024
|
|
N-nitroso cyclamate
|
|
9
|
759
|
March 15, 2024
|
|
Lack of effect of antioxidants on Biopharmaceutics Classification System (BCS) Class III drug permeability -Pub
|
|
1
|
533
|
March 13, 2024
|
|
Updated: IPEC Position Paper on Role of Excipients in Determining N-Nitrosamine Risks for Drug Products
|
|
3
|
1260
|
March 7, 2024
|